... a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease. Fabry disease is a rare genetic disorder caused ...
Pediatric neuropathologisst successfully mitigated some of the effects of a muscular disease by using a new targeted enzyme replacement therapy strategy.
... ., have demonstrated in mice the first successful use of enzyme replacement therapy to prevent hypophosphatasia (HPP), a primary skeletal disease of genetic origin. This discovery ...
... have demonstrated in mice the first successful use of enzyme replacement therapy to prevent hypophosphatasia, a primary skeletal disease of genetic origin. This discovery lays ...
... men with Fabry disease, enzyme replacement therapy (ERT) with agalsidase alfa slows deterioration of kidney function, reports a study ...
... Children's Hospital. In a subset of patients, the enzyme replacement therapy helps initially, but becomes ineffective over time. "I think this study begins ...
... and motor skills, visual impairment, seizures and premature death. Unfortunately, intravenous enzyme replacement therapy is not a viable treatment approach as it is nearly ...
... and cause cell damage and destruction. Enzyme replacement therapy has been successful in treating one form of lysosomal storage disease called Gaucher disease ...
... colleagues are now exploring potential enzyme replacement therapies to either restore hearing or prevent ... could be tested at birth and immediately put on enzyme replacement therapy to reduce or prevent the hearing loss ...
... . The researchers wonder if enzyme replacement therapy might be a possible method for treating some types of stuttering in the future. The researchers estimate ...
... properly. The primary treatment option is enzyme replacement therapy, which is given intravenously, to break down the accumulated fatty substances. Eliglustat tartrate ...
... , where the current standard of care, enzyme replacement therapy, is ineffective," said team leader Jeffery ... engineering and then is injected into the patient. Enzyme replacement therapy is an effective way to restore many patients ...
... to reduce MPS I symptoms with enzyme replacement therapy. Especially important was the prevention of clinical ... for other inherited diseases to determine if they need the enzyme replacement therapy. "There is a test under development to identify ...
... of the disease. Some mucopolysaccharidoses can be temporarily treated with enzyme replacement therapies, but the body's blood-brain barrier blocks neurological benefit. There is no current ...
... with Fabry disease who are receiving, or are candidates for, enzyme replacement therapy with agalsidase alfa." This study compared ... % of the women and 29% of the children were receiving enzyme replacement therapy with agalsidase alfa. The average age ...
